http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014174899-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f226bb366267a4837d7dd012ef7a562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e9aee13868bfedebe2df1f13cda5490
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2527-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
filingDate 2014-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1540b86886ad60b9f740e74698945ff6
publicationDate 2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014174899-A1
titleOfInvention Compressed cell or compressed tissue as cell model of pathological condition and manufacturing method therefor
abstract The purpose of the present invention is to provide cultured cells necessary for elucidating the pathology of obesity, metabolic syndrome, diabetes, dyslipidemia, hypertension or atherosclerosis and screening diagnostic drugs/therapeutic drugs. It was discovered that cells (tissue) similar to obese fat cells of a desired pathology could be manufactured using a cell compression culturing method of compressing normal fat cells or normal fat tissue or obese fat cells or obese fat tissue and culturing. As a result, use of said compressed fat cells (tissue) makes possible a novel method with which compounds capable of treating metabolic syndrome, etc. can be screened in a system that is more similar to a living body.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018113959-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017146124-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017146124-A1
priorityDate 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002531118-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012010600-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011014597-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28280

Total number of triples: 26.